Valeant (VRX) August weekly volatility increases into Q2 and outlook
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Valeant Pharma (NYSE: VRX) August weekly call option implied volatility is at 157, August is at 109, September is at 84; compared to its 52-week range of 34 to 175 into Q2 results on August 9.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Valeant Pharma (VRX) Moves Off Lows on Bill Miller Comments
- Under Armour (UA) puts active onto Q3 and outlook
- Capital One (COF) volatility flat into Q3 and outlook
Create E-mail Alert Related CategoriesOption EPS Action, Options, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!